| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2017-03-23 | niraparib | front-line ovarian cancer, lung cancer, breast cancer | 2,3 | Tesaro (US - MA) | Cancer - Oncology |
| 2017-03-22 | nivolumab and tivozanib (N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N´-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate) and Opdivo® (nivolumab) | advanced renal cell carcinoma | 1-2 | Aveo Oncology (USA - MA) | Cancer - Oncology |
| 2017-03-22 | GLPG3067 | cystic fibrosis | 1 | Galapagos (Belgium) AbbVie (USA - IL) | Rare diseases - Genetic diseases |
| 2017-03-22 | serelaxin - RLX030 | acute heart failure | 3 | Novartis (Switzerland) | Cardiovascular diseases |
| 2017-03-21 | MIN-102 (5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride) | X-linked adrenoleukodystrophy | 1 | Minoryx Therapeutics (Spain) | Rare diseases - Genetic diseases |
| 2017-03-21 | brilacidin | ulcerative proctitis/ulcerative proctosigmoiditis | 2 | Cellceutix (USA - MA), now Innovation Pharmaceuticals (USA - MA) | Inflammatory diseases |
| 2017-03-20 | nintedanib | progressive fibrosing interstitial lung disease (PF-ILD) | 3 | Boehringer Ingelheim (Germany) | Lung diseases - Respiratory diseases |
| 2017-03-20 | X-linked Myotubular Myopathy (XLMTM) | Audentes Therapeutics (USA - CA) | Rare diseases - Genetic diseases - Neuromuscular diseases | ||
| 2017-03-20 | erymethionase (ERY-MET) | preclinical | Erytech Pharma (France) | Cancer - Oncology | |
| 2017-03-20 | NKTR-181 | patients with chronic low back pain who are also opioid-naïve | 3 | Nektar Therapeutics (USA - CA) | CNS diseases |
| 2017-03-20 | SYNT002 | preclinical | Syntimmune (USA - MA) | ||
| 2017-03-17 | Jardiance® (empagliflozin) | chronic heart failure | 3 | Boehringer Ingelheim (Germany) Eli Lilly (USA - IN) | Cardiovascular diseases |
| 2017-03-17 | RGX-501 | homozygous familial hypercholesterolemia (HoFH) | 1-2 | RegenXBio (USA - MD) | Rare diseases - Genetic diseases - Metabolic diseases |
| 2017-03-16 | Pollinex® Quattro Birch | birch pollen induced seasonal allergic rhinitis | 3 | Allergy Therapeutics (UK) | Allergic diseases |
| 2017-03-15 | VTS-270 (2-hydroxypropyl-?-cyclodextrin) | Niemann-Pick disease type C1 | 2-3 | Vtesse (USA - MD) | Rare diseases - Genetic diseases |
| 2017-03-14 | QGC001 | preclinical | Quantum Genomics (France) | Cardiovascular diseases | |
| 2017-03-13 | AlloCSC-01 - allogeneic human cardiac stem cells (CSCs) | acute myocardial infarction | 1-2 | Coretherapix (Spain), now Tigenix (Belgium) | Cardiovascular diseases |
| 2017-03-10 | filgotinib | small bowel Crohn's disease | 2 | Galapagos (Belgium) Gilead Sciences (USA - CA) | Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
| 2017-03-10 | filgotinib | fistulizing Crohn's disease | 2 | Galapagos (Belgium) Gilead Sciences (USA - CA) | Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
| 2017-03-09 | SENS-111 | acute vertigo | 2 | Sensorion (France) |
